Paradigm Biocapital Advisors LP - 23 Jul 2025 SCHEDULE 13G Report for Cidara Therapeutics, Inc. Common Stock, $0.0001 par value per share (CDTX)

Filing Manager
Paradigm Biocapital Advisors LP
Reporting Manager
Paradigm BioCapital Advisors LP
Security
Cidara Therapeutics, Inc. Common Stock, $0.0001 par value per share
Symbol
CDTX
Shares outstanding
20,153,804 shares
Disclosed Ownership
1,128,613 shares
Ownership
5.6%
Form type
SCHEDULE 13G
Filing time
30 Jul 2025, 16:14:23 UTC
Date of event
23 Jul 2025
Next filing
14 Nov 2025
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Paradigm BioCapital Advisors LP 5.6% 1,128,613 1,128,613 0 /s/ David K. Kim David K. Kim / Authorized Signatory
Paradigm BioCapital Advisors GP LLC 5.6% 1,128,613 1,128,613 0 /s/ David K. Kim David K. Kim / Authorized Signatory
Senai Asefaw, M.D. 5.6% 1,128,613 1,128,613 0 /s/ Senai Asefaw, M.D. N/A
Paradigm BioCapital International Fund Ltd. 4.9% 994,177 994,177 0 /s/ David K. Kim David K. Kim / Authorized Signatory